Overslaan en naar de inhoud gaan

Hoe kunnen we u helpen?

Deze pagina is niet beschikbaar in deze taal. Deze pagina is beschikbaar in de volgende talen:

  • Engels
  • 20-12-2018

The Court of Justice of the European Union (CJEU) recently ruled that, unlike medicinal products, medical devices incorporating an ancillary drug substance cannot benefit from supplementary protection certificate (SPC) protection.

Please read more on this topic in our newsletter.

Cookie melding

We care about your privacy. We only use cookies strictly necessary to ensure the proper functioning of our website. You can find more information on cookies and on how we handle your personal data in our Privacy and Cookie Policy.